Dissemination

A new OBERON publication
27 September 2024
> Dissemination > News & Press Releases > Publications

Extracellular vesicles as a biomarkers for endocrine disruption After studying the toxicity of DEHP in hepatic cells with regards to MASLD (Metabolic dysfunction-Associated Steatotic Liver Disease), our team at Inserm Rennes wrote an article about extracellular vesicles potential of being biomarkers of endocrine disruption. Read this article in Biochimie. Article in Elsevier

Omics and epidemiology
9 August 2024
> Dissemination > Publications

Integration of Omics in epidemiological studies A review was done last year on omics linked to epidemiological study. The article is by Léa Maître from ISGlobal and describes the application of omics in epidemiological study. This work can help epidemiologist to understand the interest and apply omics to their study. Article in ScienceDirect

New publication on adipose tissue
24 july 2024
> Dissemination > News & Press Releases > Publications

A new OBERON article on adipose tissue physiology A new article by Jan Kucera was published on the effect of EDs on adipose tissue cells. These findings show the importance of models to study EDC-adipocyte interactions. Conclusions could guide strategies to reduce the negative impacts of EDC exposure on adipose tissue. Article on Wiley

A new article about results from the Sépages cohort
9 July 2024
> Dissemination

Fetal and Infancy Exposure to Phenols, Parabens, and Phthalates Article in EHP A study from the SEPAGES Cohort is focusing on post-natal growth and pre-natal and early life exposure to EDs. Here, Marion Ouidir from Inserm presents an article about these epidemiological results. Samples in mothers and infants contain phenols, parabens, phthalates, and non-phthalate plasticizers Read the full article…

A new OBERON article was published in epidemiology
9 July 2024
> Dissemination > Publications

An association between EDs and metabolic syndrome in children? Metabolic Syndrome is the association of various pathologies related to poor health of the metabolism. Thus, it can group cardiovascular diseases with obesity and type 2 diabetes among other health issues. Currently, it affects 1 in 4 adults worldwide.  This article by Nuria Güil-Oumrait from ISGlobal, Read the full article…

New OBERON publication
8 July 2024
> Dissemination > Publications

Association between mother's diet during pregnancy, exposure to POPs and obesity An article by German Cano Sancho published last year shows athe correlation between the mother's nutrition during pregnancy and the impact of the exposure to POPs on childhood obesity. A previous publication by Nuria Güil already states of an association between prenatal exposure to Read the full article…

Final Annual Meeting
21 May 2024
> Dissemination

OBERON 5th Annual Meeting OBERON project held its 5th and final annual meeting on the 16th and 17th of May 2024. This meeting was in Paris, France where the coordinator team at Inserm is based. Coordinator Karine Audouze chaired the meeting and presented alongside partners from Universidad Miguel Hernández de Elche, RECETOX, IBP, ISGlobal, Ineris, Read the full article…

New OBERON publication on liver metabolic disruption
15 May 2024
> Dissemination > News & Press Releases > Publications

OBERON models and tools in other application A study by Recetox and the Czech Science Foundation project, focuses on a hepatotoxic cyanotoxin cylindrospermopsin. This study does not investigate Endocrine Disruption but it addresses liver metabolic disruption using 3D in vitro model and tools developed within the OBERON project. Those tools were used to study metabolic Read the full article…

New OBERON publication on AOP-Wiki
8 March 2024
> Dissemination > News & Press Releases > Publications

New publication on the use of the AOP-Wiki database Since today, the 8th of March, an article authored by Thomas Jaylet (Université Paris Cité) is accessible in Frontiers. The article showcases the AOP-Wiki database and investigates available AOPs. This work allows for a mapping of current knowledge and understanding of diseases at a molecular level. Read the full article…

© OBERON 2019, Website Created by FMOSys